Real-World Data From Over 10 Years In The Tysabri (R) Observational Program: Long-Term Safety And Effectiveness Of Natalizumab In Relapsing-Remitting Multiple Sclerosis Patients
MULTIPLE SCLEROSIS JOURNAL（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要